Signaling pathways that underlie T-cell co-stimulation and co-inhibition for cancer immunotherapy

Date 03 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session New frontiers in immunotherapy (2): New targets and agents beyond checkpoint inhibition
Topics Cancer Immunology and Immunotherapy
Translational Research
Presenter Ignacio Melero